Digestive Diseases and Sciences

, Volume 48, Issue 4, pp 815–820 | Cite as

Risk Factors for Hepatitis C Virus Infection Among Patients Receiving Health Care in a Department of Veterans Affairs Hospital

  • Girish Mishra
  • C. Sninsky
  • Robert Roswell
  • S. Fitzwilliam
  • Kenneth C. Hyams


A cross-sectional, seroepidemiological study was conducted to determine the prevalence and risk factors for hepatitis C virus (HCV) infection among veterans receiving health care from the VA. Among 274 evaluated outpatients, anti-HCV was found in 27 (9.9%). The prevalence of anti-HCV was 3.7% among 190 individuals who reported no illicit drug use compared to 24.7% among 81 subjects who had used drugs (P < 0.001). The prevalence of anti-HCV was 4.8% among 208 veterans who had never been incarcerated compared to 27.9% among 61 veterans who had been incarcerated (P < 0.001). A multivariate model found the following factors to be independently associated with anti-HCV: having used illicit drugs [odds ratio (OR) = 3.7, 95% CI 1.3–11.8; P = 0.001), having been incarcerated ( OR = 4.4, 95% CI 1.7–10.9; P = 0.001), and a yearly income less than US $10,000 ( OR = 3.5, 95% CI 1.3–9.4; P = 0.002). Because HCV infection was most strongly associated with illicit drug use, incarceration, and low income, these risk factors should be utilized to develop screening strategies among VA patients.

hepatitis C viral hepatitis Veterans Affairs hospital epidemiology military medicine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis N Engl J Med 321:1494-1500, 1989Google Scholar
  2. 2.
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562, 1999Google Scholar
  3. 3.
    McQuillan GM, Alter MJ, Moyer LA: A population based-based serologic study of hepatitis C virus infection in the United States. In Viral Hepatitis and Liver Disease. M Rizzetto, RH Purecll, JL Gerin, G Verme (eds). Turin, Italy: Edizioni Minerva Medica; 1997, pp 267-270Google Scholar
  4. 4.
    Pham DQ, Walse D, Montgomery J, Buskell-Bales Z, Collier K, Lokken G, Claggett J, Wilson L, Biswas R, Gibert C, Seef LB: Seroepidemiology of hepatitis C and B in an urban VA medical center. Hepatology 326A, 1994Google Scholar
  5. 5.
    Kizer KW: Under Secretary for Health's Information Letter—Hepatitis C: Standards for Provider Evaluation and Testing. Washington, DC, Department of Veterans Affairs, Veterans Health Administration, June 11, 1998 (IL 10-98-013)Google Scholar
  6. 6.
    Late M: Action urged to stem hepatitis C. US Med 34:3,42,43, 1998Google Scholar
  7. 7.
    Roselle GA, Mendenhall CL, Danko LH: A four-year review of patients with hepatitis C antibody in Department of Veterans Affairs facilities. Mil Med 162:711-714, 1997Google Scholar
  8. 8.
    Malone JD, Hyams KC, Hawkins RE, Sharp TW, Daniell FD: Risk factors for sexually-trasmitted diseases among deployed military personnel. J STD 20:294-298, 1993Google Scholar
  9. 9.
    Long GE, Rickman LS: Infectious complications of tattoos. Clin Infect Dis 18:610-619, 1994Google Scholar
  10. 10.
    Samantha S, Tweeten M, Rickman LS: Infectious complications of body piercing: Clin Infect Dis 26:735-740, 1998Google Scholar
  11. 11.
    Dodd RY: Infectious risk of plasma donations: relationship to safety of intravenous immune globulins. Clin Exp Immunol 104:31-34, 1996Google Scholar
  12. 12.
    Hyams KC, Riddle J, Rubertone M, Trump D, Alter MJ, Cruess DF, Han X, Nainam OV, Seeff LB, Mazzuchi JF, Bailey S: The risk of hepatitis C virus infection in the US military: A serosurvey of 21,000 troops. Am J Epidemiol 153:764-770, 2001Google Scholar
  13. 13.
    Bukh J, Purcell RH, Miller RH: Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 89:187-191, 1992Google Scholar
  14. 14.
    Urdea MS, Horn T, Fultz TJ, Anderson M, Running JA, Hamren S, Ahle D, Chang CA: Branched DNA amplication for the sensitive, direct detection of human hepatitis viruses. Nuclere Acids Res Symp Ser 24:197-200, 1991Google Scholar
  15. 15.
    Austin E, Jensen B, Leete J, De L'Aune W, Bhatnagar J, Racine M, Braun JE: Prevalence of hepatitis C virus seropositivity among hospitalized veterans. Am J Med Sci 319:353-359, 2000Google Scholar
  16. 16.
    Cheung RC: Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 95:740-747, 2000Google Scholar
  17. 17.
    Briggs ME, Baker C, Hall R, Gaziano MJ, Gagnon D, Bzowej N, Wright TL: Prevalence and risk factors for hepatitis C virus infection at an urban veterans administration medical center. Hepatology 34:1200-1205, 2001Google Scholar
  18. 18.
    Brau N, Bini EJ, Shahidi A, Aytarnan A, Xiao P, Stancic S, Eng R, Brown ST, Paronetto F: Prevalence of Hepatitis C and Coinfection with HIV among United States Veterans in the New York City Metropolitan Area. Am J Gastroenterol 97:2071-2078, 2002Google Scholar
  19. 19.
    van Doornum GJJ, Hooykaas C, Cuypers MT, van der Linden MM, Coutinho RA: Prevalence of hepatitis C virus infections among heterosexuals with multiple partners. J Med Virol 35:22-27, 1991Google Scholar
  20. 20.
    Brettler DB, Mannucci PM, Gringeri A, Rasko JE, Forsberg AD, Rumi MG, Garsia RJ, Rickard KA, Colombo M: The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected males: An international, multicenter study. Blood 80:540-543, 1992Google Scholar
  21. 21.
    Haley RW, Fischer RP: Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatits C serologic status. Medicine (Baltimore) 80:134-151, 2001Google Scholar
  22. 22.
    Silverman AL, Sekhon JS, Saginaw SJ, Wiedbruk D, Balasubramaniam M, Gordon SC: Tattoo application is not associated with an increased risk for chronic viral hepatitis. Am J Gastroenterol 95:1312-1315, 2000Google Scholar

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  • Girish Mishra
    • 1
  • C. Sninsky
    • 1
  • Robert Roswell
    • 2
  • S. Fitzwilliam
    • 1
  • Kenneth C. Hyams
    • 3
  1. 1.University of Florida and Malcolm Randall VA Medical CenterFloridaUSA
  2. 2.Veterans Integrated Services Network 8FloridaUSA
  3. 3.VA Central OfficeWashington, DCUSA

Personalised recommendations